# Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia

> **NCT00595504** · PHASE4 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 25 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder
- Schizophreniform Disorders

## Interventions

- **DRUG:** Ramelteon
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00595504
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2012-09-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00595504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00595504, "Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00595504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*